Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Abroad (travel likely)RecruitingPHASE3
Conditions
T2DM · Diabete Type 2 · DM
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Celltrion, Seoul, South Korea